Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-30 @ 12:40 AM
Study NCT ID:
NCT07238569
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-11-20
First Post:
2025-11-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-12-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-05-23
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-16
First Submit QC Date:
None
Study First Post Date:
2025-11-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-16
Last Update Post Date:
2025-11-20
Last Update Post Date Type:
ESTIMATED